Curaleaf Holdings (CURLF) Profit After Tax (2019 - 2026)

Curaleaf Holdings (CURLF) posted quarterly Profit After Tax of $69.8 million for Q1 2026, up 215.83% year-on-year from $22.1 million in Q1 2025, and up 202.31% on a QoQ basis from -$68.2 million in Q4 2025.

Curaleaf Holdings (CURLF) Profit After Tax (2019 - 2026) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Profit After Tax for 8 consecutive years, with $69.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Profit After Tax rose 215.83% year-over-year to $69.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$103.6 million (up 52.99% YoY) and the FY2025 annual result came in at -$228.2 million, down 7.82% from the prior year.
  • Profit After Tax climbed to $69.8 million in Q1 2026 per CURLF's latest filing, from -$68.2 million in the prior quarter.
  • Over the last five years, Profit After Tax for CURLF reached as high as $69.8 million in Q1 2026 and fell as low as -$57.7 billion in Q4 2023.
  • A 5-year average of -$3.4 billion and a median of -$51.6 million in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2023 — Profit After Tax slumped 21841.85% — and 2026, when it surged 215.83%.
  • Year by year, Profit After Tax stood at -$262.7 million in 2022, then sank by 21841.85% to -$57.7 billion in 2023, then surged by 99.88% to -$67.2 million in 2024, then declined by 1.56% to -$68.2 million in 2025, then jumped by 202.31% to $69.8 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered $69.8 million, -$68.2 million, and -$54.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 369.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn 69.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 69.78 Mn
Dec 31, 2025 -68.21 Mn
Sep 30, 2025 -54.55 Mn
Jun 30, 2025 -50.60 Mn
Mar 31, 2025 -60.25 Mn
Dec 31, 2024 -67.17 Mn
Sep 30, 2024 -44.35 Mn
Jun 30, 2024 -48.55 Mn
Mar 31, 2024 -51.58 Mn
Dec 31, 2023 -57.65 Bn
Sep 30, 2023 -67.81 Mn
Jun 30, 2023 -66.59 Mn
Mar 31, 2023 -43.88 Mn
Dec 31, 2022 -262.75 Mn
Sep 30, 2022 -41.42 Mn
Jun 30, 2022 -17.26 Mn
Mar 31, 2022 -21.76 Mn
Dec 31, 2021 -75.50 Mn
Sep 30, 2021 57.67 Mn
Jun 30, 2021 8.28 Mn